Headquartered in Melbourne, Australia, Gelteq (NASDAQ: GELS) is a biotechnology company that has developed Gelteq® technology, a proprietary delivery technology designed to improve how active ingredients are formulated, stabilised and absorbed by the body.
Gelteq specializes in research and development, product creation and manufacturing for partners across pharmaceutical, consumer health and animal health markets. Gelteq® technology aims to address challenges associated with conventional drug and nutrient delivery by enhancing bioavailability, improving patient compliance, and enabling precise dosing.
Gelteq holds multiple patent families that cover a range of applications for our proprietary Gelteq® technology